Batroxobin binds fibrin with higher affinity and promotes clot expansion to a greater extent than thrombin

Journal of Biological Chemistry

Volumn 288, Issue 23, 2013, Pages 16862-16871

  Vu, Trang T ^a,b   Stafford, Alan R ^a,b   Leslie, Beverly A ^a,b   Kim, Paul Y ^a,b   Fredenburgh, James C ^a,b   Weitz, Jeffrey I ^a,b  

^a MCMASTER UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AFFINITY INTERACTIONS; HIGH AFFINITY; ISOFORMS; MICROVASCULAR THROMBOSIS; SERINE PROTEASE; TERMINAL DOMAIN;

AMINO ACIDS; E REGION;

ENZYMES;

BATROXOBIN; FIBRIN; FIBRINOGEN; FIBRINOGEN VARIANT; THROMBIN;

ARTICLE; BINDING AFFINITY; BINDING COMPETITION; BINDING SITE; BLOOD CLOTTING; CATALYSIS; CONTROLLED STUDY; MOLECULAR DYNAMICS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION;

BATROXOBIN; BLOOD COAGULATION FACTORS; FIBRIN; FIBRINOGEN; FIBRINOPEPTIDES; SNAKE VENOM; THROMBIN;

ANIMALS; BATROXOBIN; BINDING SITES; FIBRINOPEPTIDE A; HUMANS; PROTEIN BINDING; PROTEIN ISOFORMS; THROMBIN;

BOTHROPS ATROX;

EID: 84878760414     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.464750     Document Type: Article

References (51)

1. Wolberg, A. S. (2012) Determinants of fibrin formation, structure, and function. Curr. Opin. Hematol. 19, 349-356
2. Mosesson, M. W. (2005) Fibrinogen and fibrin structure and functions. J. Thromb. Haemost. 3, 1894-1904
3. Wolfenstein-Todel, C., and Mosesson, M. W. (1980) Human plasma fibrinogen heterogeneity: evidence for an extended carboxyl-terminal sequence in a normal γ chain variant (γ′). Proc. Natl. Acad. Sci. U.S.A. 77, 5069-5073 (Pubitemid 11195509)
4. Chung, D. W., and Davie, E. W. (1984) γ and γ′ chains of human fibrinogen are produced by alternative mRNA processing. Biochemistry 23, 4232-4236
5. Fornace, A. J., Jr., Cummings, D. E., Comeau, C. M., Kant, J. A., and Crabtree, G. R. (1984) Structure of the human γ-fibrinogen gene. Alternate mRNA splicing near the 3′ end of the gene produces γA and γB forms of γ-fibrinogen. J. Biol. Chem. 259, 12826-12830 (Pubitemid 15211186)
6. Lovely, R. S., Kazmierczak, S. C., Massaro, J. M., D'Agostino, R. B., Sr., O'Donnell, C. J., and Farrell, D. H. (2010) γ′ fibrinogen: evaluation of a new assay for study of associations with cardiovascular disease. Clin. Chem. 56, 781-788
7. van den Herik, E. G., Cheung, E. Y., de Lau, L. M., den Hertog, H. M., Leebeek, F. W., Dippel, D. W., Koudstaal, P. J., and de Maat, M. P. (2011) γ′/total fibrinogen ratio is associated with short-term outcome in ischaemic stroke. Thromb. Haemost. 105, 430-434
8. Blombäck, B., Hessel, B., Hogg, D., and Therkildsen, L. (1978) A two-step fibrinogen-fibrin transition in blood coagulation. Nature 275, 501-505 (Pubitemid 9020557)
9. Mullin, J. L., Gorkun, O. V., Binnie, C. G., and Lord, S. T. (2000) Recombinant fibrinogen studies reveal that thrombin specificity dictates order of fibrinopeptide release. J. Biol. Chem. 275, 25239-25246
10. Weitz, J. I., Hudoba, M., Massel, D., Maraganore, J., and Hirsh, J. (1990) Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors. J. Clin. Invest. 86, 385-391 (Pubitemid 20271869)
11. Huntington, J. A. (2005) Molecular recognition mechanisms of thrombin. J. Thromb. Haemost. 3, 1861-1872
12. Adams, T. E., and Huntington, J. A. (2006) Thrombin-cofactor interactions: structural insights into regulatory mechanisms. Arterioscler. Thromb. Vasc. Biol. 26, 1738-1745 (Pubitemid 44305326)
13. Fredenburgh, J. C., Stafford, A. R., Pospisil, C. H., and Weitz, J. I. (2004) Modes and consequences of thrombin's interaction with fibrin. Biophys. Chem. 112, 277-284 (Pubitemid 39574430)
14. Mosesson, M. W. (2007) Update on antithrombin I (fibrin). Thromb. Haemost. 98, 105-108
15. Meh, D. A., Siebenlist, K. R., and Mosesson, M. W. (1996) Identification and characterization of the thrombin-binding sites on fibrin. J. Biol. Chem. 271, 23121-23125 (Pubitemid 26314747)
16. Pospisil, C. H., Stafford, A. R., Fredenburgh, J. C., and Weitz, J. I. (2003) Evidence that both exosites on thrombin participate in its high affinity interaction with fibrin. J. Biol. Chem. 278, 21584-21591 (Pubitemid 36792557)
17. Becker, D. L., Fredenburgh, J. C., Stafford, A. R., and Weitz, J. I. (1999) Exosites 1 and 2 are essential for protection of fibrin-bound thrombin from heparin-catalyzed inhibition by antithrombin and heparin cofactor II. J. Biol. Chem. 274, 6226-6233 (Pubitemid 29111032)
18. Fredenburgh, J. C., Stafford, A. R., Leslie, B. A., and Weitz, J. I. (2008) Bivalent binding to γA/γ′-fibrin engages both exosites of thrombin and protects it from inhibition by the antithrombin-heparin complex. J. Biol. Chem. 283, 2470-2477
19. Da Graca Salomao, M., Wuster, W., Thorpe, R. S., and Touzet, J.-M. (1997) DNA evolution of South American pitvipers of the genus Bothrops (Reptilia:Serpentes:Viperidae). Symp. Zool. Soc. Lond. 70, 89-98
20. Aronson, D. L. (1976) Comparison of the actions of thrombin and the thrombin-like venom enzymes ancrod and batroxobin. Thromb. Haemost. 36, 9-13
21. Braud, S., Bon, C., and Wisner, A. (2000) Snake venom proteins acting on hemostasis. Biochimie 82, 851-859
22. Latallo, Z. S. (1983) Retrospective study on complications and adverse effects of treatment with thrombin-like enzymes-a multicentre trial. Thromb. Haemost. 50, 604-609
23. Stocker, K. F. (1998) in Hemostasis and Animal Venoms (Pirkle, H., and Markland, F., eds) pp. 525-540, Marcel Dekker, Inc., Los Angeles
24. Xu, G., Liu, X., Zhu, W., Yin, Q., Zhang, R., and Fan, X. (2007) Feasibility of treating hyperfibrinogenemia with intermittently administered batroxobin in patients with ischemic stroke/transient ischemic attack for secondary prevention. Blood Coagul. Fibrinolysis 18, 193-197 (Pubitemid 46232842)
25. Wang, J., Zhu, Y. Q., Liu, F., Li, M. H., Zhao, J. G., Tan, H. Q., Wang, J. B., Cheng, Y. S., and Zhang, P. L. (2010) Batroxobin for prevention of restenosis in diabetic patients after infrapopliteal arterial angioplasty: a small randomized pilot trial. Ann. Vasc. Surg. 24, 876-884
26. White, J. (2005) Snake venoms and coagulopathy. Toxicon 45, 951-967
27. Isbister, G. K. (2010) Snakebite doesn't cause disseminated intravascular coagulation: coagulopathy and thrombotic microangiopathy in snake envenoming. Semin. Thromb. Hemost. 36, 444-451
28. Schaefer, A. V., Leslie, B. A., Rischke, J. A., Stafford, A. R., Fredenburgh, J. C., and Weitz, J. I. (2006) Incorporation of fragment X into fibrin clots renders them more susceptible to lysis by plasmin. Biochemistry 45, 4257-4265
29. Lovely, L. P., Meyer, W. R., Ekstrom, R. D., and Golden, R. N. (2003) Effect of stress on pregnancy outcome among women undergoing assisted reproduction procedures. South. Med. J. 96, 548-551 (Pubitemid 38281712)
30. Vu, T. T., Stafford, A. R., Leslie, B. A., Kim, P. Y., Fredenburgh, J. C., and Weitz, J. I. (2011) Histidine-rich glycoprotein binds fibrin(ogen) with high affinity and competes with thrombin for binding to the γ′- chain. J. Biol. Chem. 286, 30314-30323
31. Kretz, C. A., Cuddy, K. K., Stafford, A. R., Fredenburgh, J. C., Roberts, R., and Weitz, J. I. (2010) HD1, a thrombin- and prothrombin-binding DNA aptamer, inhibits thrombin generation by attenuating prothrombin activation and thrombin feedback reactions. Thromb. Haemost. 103, 83-93
32. Olexa, S. A., and Budzynski, A. Z. (1979) Binding phenomena of isolated unique plasmic degradation products of human cross-linked fibrin. J. Biol. Chem. 254, 4925-4932 (Pubitemid 9204197)
33. Petrera, N. S., Stafford, A. R., Leslie, B. A., Kretz, C. A., Fredenburgh, J. C., and Weitz, J. I. (2009) Long range communication between exosites 1 and 2 modulates thrombin function. J. Biol. Chem. 284, 25620-25629
34. Cooper, A. V., Standeven, K. F., and Ariëns, R. A. (2003) Fibrinogen γ-chain splice variant γ′ alters fibrin formation and structure. Blood 102, 535-540 (Pubitemid 36841972)
35. Moen, J. L., Gorkun, O. V., Weisel, J. W., and Lord, S. T. (2003) Recombinant BßArg14His fibrinogen implies participation of N terminus of Bβ chain in desA fibrin polymerization. Blood 102, 2466-2471 (Pubitemid 37193584)
36. Stone, S. R., and Hofsteenge, J. (1986) Kinetics of the inhibition of thrombin by hirudin. Biochemistry 25, 4622-4628 (Pubitemid 16010197)
37. Lord, S. T., Rooney, M. M., Hopfner, K. P., and Di Cera, E. (1995) Binding of fibrinogen Aα1-50-β-galactosidase fusion protein to thrombin stabilizes the slow form. J. Biol. Chem. 270, 24790-24793
38. Bode, W., Mayr, I., Baumann, U., Huber, R., Stone, S. R., and Hofsteenge, J. (1989) The refined 1.9 Å crystal structure of human α-thrombin: interaction with D-Phe-Pro-Arg chloromethyl ketone and significance of the Tyr-Pro-Pro-Trp insertion segment. EMBO J. 8, 3467-3475 (Pubitemid 19273577)
39. Rose, T., LeMosy, E. K., Cantwell, A. M., Banerjee-Roy, D., Skeath, J. B., and Di Cera, E. (2003) Three-dimensional models of proteases involved in patterning of the Drosophila embryo. Crucial role of predicted cationbinding sites. J. Biol. Chem. 278, 11320-11330 (Pubitemid 36792689)
40. Pechik, I., Madrazo, J., Mosesson, M. W., Hernandez, I., Gilliland, G. L., and Medved, L. (2004) Crystal structure of the complex between thrombin and the central "E"-region of fibrin. Proc. Natl. Acad. Sci. U.S.A. 101, 2718-2723 (Pubitemid 38327677)
41. Di Cera, E., and Cantwell, A. M. (2001) Determinants of thrombin specificity. Ann. N.Y. Acad. Sci. 936, 133-146
42. Parry, M. A., Jacob, U., Huber, R., Wisner, A., Bon, C., and Bode, W. (1998) The crystal structure of the novel snake venom plasminogen activator TSV-PA: a prototype structure for snake venom serine proteinases. Structure 6, 1195-1206 (Pubitemid 28434121)
43. Castro, H. C., Zingali, R. B., Albuquerque, M. G., Pujol-Luz, M., and Rodrigues, C. R. (2004) Snake venom thrombin-like enzymes: from reptilase to now. Cell. Mol. Life Sci. 61, 843-856 (Pubitemid 38651003)
44. Henschen-Edman, A. H., Theodor, I., Edwards, B. F., and Pirkle, H. (1999) Crotalase, a fibrinogen-clotting snake venom enzyme: primary structure and evidence for a fibrinogen recognition exosite different from thrombin. Thromb. Haemost. 81, 81-86 (Pubitemid 29041655)
45. Serrano, S. M., and Maroun, R. C. (2005) Snake venom serine proteinases: sequence homology vs. substrate specificity, a paradox to be solved. Toxicon 45, 1115-1132 (Pubitemid 40732585)
46. Maroun, R. C., and Serrano, S. M. (2004) Identification of the substrate-binding exosites of two snake venom serine proteinases: molecular basis for the partition of two essential functions of thrombin. J. Mol. Recognit. 17, 51-61 (Pubitemid 38231464)
47. Zhang, Y., Wisner, A., Maroun, R. C., Choumet, V., Xiong, Y., and Bon, C. (1997) Trimeresurus stejnegeri snake venom plasminogen activator. Site-directed mutagenesis and molecular modeling. J. Biol. Chem. 272, 20531-20537 (Pubitemid 27355610)
48. Koopman, J., Haverkate, F., Lord, S. T., Grimbergen, J., and Mannucci, P. M. (1992) Molecular basis of fibrinogen Naples associated with defective thrombin binding and thrombophilia. Homozygous substitution of Bβ68Ala-Thr. J. Clin. Invest. 90, 238-244
49. Weisel, J. W., Veklich, Y., and Gorkun, O. (1993) The sequence of cleavage of fibrinopeptides from fibrinogen is important for protofibril formation and enhancement of lateral aggregation in fibrin clots. J. Mol. Biol. 232, 285-297 (Pubitemid 23245414)
50. Riedel, T., Suttnar, J., Brynda, E., Houska, M., Medved, L., and Dyr, J. E. (2011) Fibrinopeptides A and B release in the process of surface fibrin formation. Blood 117, 1700-1706
51. Liu, M., Marder, V. J., Levy, D. E., Wang, S-J., Yang, F., Paganini-Hill, A., and Fisher, M. (2011) Ancrod and fibrin formation: perspectives on mechanisms of action. Stroke 42, 3277-3280